Skip to main content
S 3116 116th Congress Senate Health Adoption and foster care Cell biology and embryology Child health Emergency medical services and trauma care Genetics Health care costs and insurance Health care coverage and access Health care quality Health programs administration and funding Health technology, devices, supplies Hospital care Medicaid Medical tests and diagnostic methods State and local government operations

Ending the Diagnostic Odyssey Act of 2019

Introduced: December 19, 2019 Introduced by: Collins, Susan M. Republican · Maine See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 19, 2019
Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S7211)
Dec 19, 2019
Introduced in Senate
 Plain-English summary Congressional Research Service

Ending the Diagnostic Odyssey Act of 2019

This bill allows state Medicaid programs to cover whole genome sequencing services for certain individuals.

Specifically, states may cover such services for individuals under the age of 21 (or a lower age, if the state chooses) and for former foster youth under the age of 26 who (1) have been referred or admitted to an intensive care unit or seen by a medical specialist for a suspected genetic or undiagnosed disease, or (2) are suspected by a medical specialist to have a neonatal- or pediatric-onset genetic disease.

The Centers for Medicare & Medicaid Services may award grants to assist states in developing plans to cover such services.

What's happening now December 19, 2019

Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S7211)

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Democratic 1